Clinical Trial Update: DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 study evaluating upfront dose-reduced chemotherapy in older adults with metastatic colorectal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Leiden University Medical Center | Conditions: Older Patients, Colorectal Cancer | Phase 3 | Status: RECRUITING